InsidersTradesSigma
서린바이오: management transactions · South Korea · DART (FSS)
DART:company-e5ef19KR·DART (FSS)Mcap 51.7Bn€Healthcare
Browse the full directors' dealings record of 서린바이오, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 서린바이오 has logged 3 insider filings. Market capitalisation: €51.7bn. The latest transaction was disclosed on 2 April 2026 — Purchase. Among the most active insiders: 황을문. All data is openly available.
3
Insider Decl.
0
Thresholds
·
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
5860.00 €
Analyst consensus
Income statement
Revenue77.09 Bn€
Gross profit17.32 Bn€22% margin
Net income732.0 M€0.9% margin
Valuation
Beta0.72
Balance sheet & cash
Market cap51.73 Bn€
Total debt11.58 Bn€
Free Cash Flow4.25 Bn€
Debt / Equity13%
Profitability & ownership
ROE0.7%
ROA0.4%
% insiders28.1%
% institutions0.0%
Last declaration on 2 April 2026
Declarations3 total
Executives●Other0DART
DART:20260310002883·details not loaded
3 of 3 declarations